<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01781559</url>
  </required_header>
  <id_info>
    <org_study_id>11.35.NRC</org_study_id>
    <nct_id>NCT01781559</nct_id>
  </id_info>
  <brief_title>Bioefficacy of Phenolic Acids</brief_title>
  <official_title>Effect of Phenolic Acids on the Human Vasculature</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nestlé</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nestlé</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective is to demonstrate the effect of phenolic acids on endothelial function.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from predose in percent change of flow-mediated dilatation at 1h compared to control treatment</measure>
    <time_frame>After 1 hour</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from predose in blood pressure at 0.5h</measure>
    <time_frame>After 30 min</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Endothelial Dysfunction</condition>
  <arm_group>
    <arm_group_label>phenolic acid + maltodextrin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>phenolic acid + maltodextrin;</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Maltodextrin</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Maltodextrin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>flavanol + maltodextrin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>flavanol + maltodextrin</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>phenolic acid</intervention_name>
    <description>phenolic acid</description>
    <arm_group_label>phenolic acid + maltodextrin</arm_group_label>
    <arm_group_label>Maltodextrin</arm_group_label>
    <arm_group_label>flavanol + maltodextrin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy, Men and women

          -  Subjects with endothelial dysfunction defined as a basal brachial artery flow-mediated
             dilatation (FMD) measurement between 3% and 8% at screening

        Exclusion Criteria:

          -  Any food allergy

          -  Abnormal blood pressure defined as follow: systolic &lt;100 or &gt;160 mmHg and diastolic
             &lt;50 or &gt;100mmHg

          -  Pregnancy or lactating women

          -  Regular consumption of cholesterol-lowering or antihypertensive medication

          -  Smokers

          -  Inability to restrain from caffeine/tea and alcohol for 12hrs prior to study visits
             (intake1 day before screening measurements (and 1 day before each visit)

          -  Not restrain the intake of multivitamin-tablets and other supplemental compounds 10
             days before the study start and throughout the study.

          -  Excessive alcohol intake defined as &gt; 280 g per week for men and &gt;210g per week for
             women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kevin Croft, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>School of Medicine and Pharmacology - University of WA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>School of Medicine and Pharmacology - University of WA</name>
      <address>
        <city>Perth</city>
        <zip>6000</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 28, 2013</study_first_submitted>
  <study_first_submitted_qc>January 30, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 1, 2013</study_first_posted>
  <last_update_submitted>December 11, 2013</last_update_submitted>
  <last_update_submitted_qc>December 11, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 12, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

